Fisher & Paykel Healthcare Stock Forecast, Price & News

-0.12 (-0.51 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume586 shs
Average Volume1,788 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive FSPKF News and Ratings via Email

Sign-up to receive the latest news and ratings for Fisher & Paykel Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Fisher & Paykel Healthcare logo

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following geographical segments: The New Zealand, North America, Europe, and Asia-Pacific. The New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration. The North America segment refers to all activities controlled by entities or employees based in the United States of America and Canada, principally sales, distribution and administration activities. The Europe segment includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, principally sales, distribution and administration activities. The Asia-Pacific segment refers to all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, principally sales, distribution and administration activities. The company was


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Frequently Asked Questions

Is Fisher & Paykel Healthcare a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fisher & Paykel Healthcare in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Fisher & Paykel Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FSPKF, but not buy additional shares or sell existing shares.
View analyst ratings for Fisher & Paykel Healthcare
or view top-rated stocks.

What stocks does MarketBeat like better than Fisher & Paykel Healthcare?

Wall Street analysts have given Fisher & Paykel Healthcare a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Fisher & Paykel Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare saw a drop in short interest during the month of August. As of August 13th, there was short interest totaling 111,900 shares, a drop of 82.6% from the July 29th total of 644,100 shares. Based on an average daily trading volume, of 900 shares, the short-interest ratio is presently 124.3 days.
View Fisher & Paykel Healthcare's Short Interest

How has Fisher & Paykel Healthcare's stock price been impacted by Coronavirus (COVID-19)?

Fisher & Paykel Healthcare's stock was trading at $15.65 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, FSPKF shares have increased by 49.1% and is now trading at $23.33.
View which stocks have been most impacted by COVID-19

Who are Fisher & Paykel Healthcare's key executives?

Fisher & Paykel Healthcare's management team includes the following people:
  • Lewis George Gradon, Chief Executive Officer, MD & Executive Director
  • Lyndal York, Chief Financial Officer
  • Andrew Robert Donald Somervell, Vice President-Products & Technology
  • Nicholas Fourie, VP-Information & Communication Technology
  • Winston Fong, Vice President-Surgical Technologies

Who are some of Fisher & Paykel Healthcare's key competitors?

What is Fisher & Paykel Healthcare's stock symbol?

Fisher & Paykel Healthcare trades on the OTCMKTS under the ticker symbol "FSPKF."

How do I buy shares of Fisher & Paykel Healthcare?

Shares of FSPKF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fisher & Paykel Healthcare's stock price today?

One share of FSPKF stock can currently be purchased for approximately $23.33.

How many employees does Fisher & Paykel Healthcare have?

Fisher & Paykel Healthcare employs 5,788 workers across the globe.

What is Fisher & Paykel Healthcare's official website?

The official website for Fisher & Paykel Healthcare is www.fphcare.com.

Where are Fisher & Paykel Healthcare's headquarters?

Fisher & Paykel Healthcare is headquartered at 15 Maurice Paykel Place, Auckland, 2013.

How can I contact Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare's mailing address is 15 Maurice Paykel Place, Auckland, 2013. The company can be reached via phone at (649) 574-0100.

This page was last updated on 9/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.